Lens power fine tuning device
Latest Novartis AG Patents:
- Modified release formulation for (-)-(3AR,4S,7AR)-4-hydroxy-4-m-tolylethynyl-octahydro-indole-1-carboxylic acid methyl ester
- Polyomavirus neutralizing antibodies
- Synthesis of prostate specific membrane antigen (PSMA) ligands
- Cell secreted minibodies and uses thereof
- Combination therapy using a chimeric antigen receptor
Description
Claims
The ornamental design for a lens power fine tuning device, as shown and described.
Referenced Cited
U.S. Patent Documents
Patent History
Patent number: D608448
Type: Grant
Filed: Oct 31, 2008
Date of Patent: Jan 19, 2010
Assignee: Novartis AG (Basel)
Inventors: Joseph Rappon (Alpharetta, GA), Peter Bergenske (Alpharetta, GA), Timothy Andrew Giles (Roswell, GA)
Primary Examiner: T. Chase Nelson
Assistant Examiner: Anhdao Doan
Attorney: Robert Ambrose
Application Number: 29/327,138
Type: Grant
Filed: Oct 31, 2008
Date of Patent: Jan 19, 2010
Assignee: Novartis AG (Basel)
Inventors: Joseph Rappon (Alpharetta, GA), Peter Bergenske (Alpharetta, GA), Timothy Andrew Giles (Roswell, GA)
Primary Examiner: T. Chase Nelson
Assistant Examiner: Anhdao Doan
Attorney: Robert Ambrose
Application Number: 29/327,138
Classifications
Current U.S. Class:
Ophthalmic (44) (D24/172)